Bulletin
Investor Alert

Regeneron Pharmaceuticals Inc.

NAS: REGN

GO
/marketstate/country/us

After Hours

/zigman2/quotes/203149337/composite

$

582.00

Change

+2.19 +0.38%

Volume

Volume 23,926

Oct 23, 2020, 7:54 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/203149337/composite

Previous close

$ 575.73

$ 579.81

Change

+4.08 +0.71%

Day low

Day high

$575.12

$582.72

Open
Open: 580.29

52 week low

52 week high

$301.79

$664.64

Open

Market cap

$61.69B

Average volume

932,952

P/E ratio

22.45

Rev. per Employee

$906,865

EPS

25.83

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/regn

MarketWatch News on REGN

  1. Regeneron gets FDA approval for Ebola drug

    6:27 p.m. Oct. 14, 2020

    - Wallace Witkowski

  2. Barron Trump had coronavirus, first lady Melania Trump reveals

    5:58 p.m. Oct. 14, 2020

    - Nicole Lyn Pesce

  3. Dow Falls After Two Setbacks in Coronavirus Drugs

    4:23 p.m. Oct. 13, 2020

    - Ben Levisohn

  4. Buying the Most-Profitable Companies Seems Simple

    9:14 a.m. Oct. 13, 2020

    - Al Root

  5. Pfizer Suit Could Be an ‘Earthquake’ for Drug Pricing

    5:23 p.m. Oct. 12, 2020

    - Eleanor Laise

  6. Forget Stimulus. This Is Why the Dow Had a Great Week.

    6:10 p.m. Oct. 11, 2020

    - Ben Levisohn

  7. Brown’s Returns Beat Big Boys of the Ivy League

    7:46 p.m. Oct. 9, 2020

    - Mary Romano

  8. More Proof That Gilead’s Treatment Helps Covid Patients

    10:12 a.m. Oct. 9, 2020

    - Bill Alpert

  9. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/regn

Other News on REGN

  1. Stocks To Watch: Big Test For Tech, New IPOs And Fisker Blaze In

    8:39 a.m. Today

    - Seeking Alpha

  2. To Find a Coronavirus Vaccine, GlaxoSmithKline Is Bonding With Its Biggest Competitors

    12:00 a.m. Today

    - Joseph Walker

  3. Covid-19 Drug Remdesivir Fully Approved by FDA

    6:09 p.m. Oct. 22, 2020

    - Joseph Walker

  4. GILD News: Gilead Stock Pops as FDA Approves Remdesivir Treatment

    5:37 p.m. Oct. 22, 2020

    - InvestorPlace.com

  5. Is It Too Late for Novavax to Profit From a Covid-19 Vaccine?

    1:31 p.m. Oct. 22, 2020

    - InvestorPlace.com

  6. Polen Capital Focus Growth Portfolio Manager Commentary Q3 2020

    11:30 a.m. Oct. 22, 2020

    - Seeking Alpha

  7. 9 Outbreak-Fueled Stocks to Buy This Week

    5:50 p.m. Oct. 21, 2020

    - InvestorPlace.com

  8. While Risky, Sorrento Therapeutics Has Many Options to Win

    12:35 p.m. Oct. 21, 2020

    - InvestorPlace.com

  9. Eaton Vance Worldwide Health Sciences Fund's Annual Report

    3:56 p.m. Oct. 20, 2020

    - GuruFocus.com

  10. 7 Ways to Minimize Your Risk in Growth Stocks

    3:37 p.m. Oct. 20, 2020

    - InvestorPlace.com

  11. Alnylam (ALNY) Gets Positive CHMP Opinion for Lumasiran

    9:55 a.m. Oct. 19, 2020

    - Zacks.com

  12. Healthcare And Biotech Outlook For The Rest Of 2020

    9:00 a.m. Oct. 19, 2020

    - Seeking Alpha

  13. 7 Large Biotechs Expected to Outperform This Earnings Season

    8:30 a.m. Oct. 17, 2020

    - 247WallSt.com

  14. Loading more headlines...
/news/pressrelease/company/us/regn

Press Releases on REGN

  1. Loading more headlines...

Rates »

Link to MarketWatch's Slice.